Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30011016HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30088012HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30086818HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30076758HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30077839HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067852HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067853HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067854HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067855HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067856HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TCGA Plot Options
Drug Information
GeneCFTR
DrugBank IDDB09280
Drug NameLumacaftor
Target IDBE0001195
UniProt IDP13569
Regulation Typemodulator
PubMed IDs26416827
CitationsKuk K, Taylor-Cousar JL: Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects. Ther Adv Respir Dis. 2015 Dec;9(6):313-26. doi: 10.1177/1753465815601934. Epub 2015 Sep 28.
GroupsApproved
Direct ClassificationPhenylpyridines
SMILESCC1=CC=C(NC(=O)C2(CC2)C2=CC=C3OC(F)(F)OC3=C2)N=C1C1=CC(=CC=C1)C(O)=O
Pathways
PharmGKBPA166114483
ChEMBLCHEMBL2103870